Dr. Nathan Christopher Steinle, MD

Dr. Steinle practices at California Retina Consultants in Bakersfield, California.

Dr. Steinle's NPI, 1942455423, was assigned on November 25, 2008. Dr. Steinle graduated from Sanford School of Medicine in 2005. Dr. Steinle holds California license A116602.

Dr. Steinle's primary practice is California Retina Consultants, at 5555 Business S Park, Bakersfield, CA 93309 in Kern County. The practice phone is (661) 325-4393.

Dr. Steinle's primary practice is California Retina Consultants in Bakersfield, California. Dr. Steinle is also affiliated with Dignity Health - Marian Regional Medical Center. Dmand AI also links Dr. Steinle to 1 more hospital, 2 medical groups, 1 group practice or clinic and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Steinle practices, 4 sites in all. Vendor and product names are available with a free account.

Retina specialist is Dr. Steinle's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Steinle is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Steinle's licenses on file in 5 states: California, South Dakota, Wyoming, Kentucky and Ohio.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Steinle treats.

CMS data shows 220,183 Medicare services from Dr. Steinle across 43 procedure codes in 2024, for 3,051 Medicare patients. Medicare paid $9,773,913 for them.

CMS counts 3,051 Medicare patients who saw Dr. Steinle in 2024. The largest group is 65 to 74, with 1,254 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.23, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Steinle's median patient age at 71, with 55% women.

In 2024, Dr. Steinle wrote 2,210 Medicare Part D claims for 561 patients. 56% of them were for generic drugs. CMS names the drug for 2,096 of them, across 18 drugs with 11 or more claims each, at $81,821 in total drug cost. In 2023, CMS named 2,040 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Steinle for performance year 2024, reported as part of a group. Dr. Steinle accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 241 procedures of cataract surgery by Dr. Steinle, more than 86% of the clinicians it reports for that procedure.

Dmand AI links 28 papers to Dr. Steinle, published from 2011 to 2025. 2017 was the busiest year, with 3. The most frequent topics are Intravitreal Injections, Visual Acuity and Angiogenesis Inhibitors. Dr. Steinle has published most often in Ophthalmic Surg Lasers Imaging Retina. Dr. Steinle's most frequent co-authors are Dilsher Singh Dhoot, MD, Robert Logan Avery, MD and Alessandro Attilio Castellarin, MD.

Dmand AI links Dr. Steinle to 4 clinical trials, 2 of them phase 4 studies. Conditions studied include Glaucoma, Neovascular and Retinal Perforations. California Retina Consultants sponsors the most, 2. Open Payments lists research payments to Dr. Steinle that name 1 trial.

CMS Open Payments shows 1,187 general payments to Dr. Steinle from 28 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 67% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $557,173. It also lists 17 research payments totaling $18,952 from 2018 to 2023, naming 1 clinical trial.

Dr. Steinle graduated from Sanford School of Medicine in 2005.

Dr. Steinle is in network with 21 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.